Innovation to Impact: Therapeutics, Diagnostics, Vaccines
Our researchers work across the full pipeline, from early-stage discovery through to clinical trials, regulatory navigation and delivery.
With expertise in diagnostics, therapeutics, vaccines, and human challenge models, we harness disruptive technologies and global partnerships to develop accessible, effective solutions.
Our research centres and units collaborate with industry, academia and policymakers to ensure breakthroughs move beyond the lab and into real-world use.
Whether tackling antimicrobial resistance or accelerating pandemic tools, we focus on impact, improving lives through research that reaches those who need it most.
Centres of Excellence
Our specialist Centres, Institutes and Units lead research into emerging and re-emerging diseases. By uniting clinical, scientific and operational expertise, they drive innovation in diagnostics, treatment and disease elimination, working with global partners to reduce burden and improve health outcomes.
Meet the team developing therapeutics, diagnostics and vaccines through world-class research and practical solutions.
Dr Kayla Barnes
Senior Lecturer and Associate Professor, Dr Barnes is a genomics researcher based at the Malawi-Liverpool Wellcome Trust whose work spans viral pathogen surveillance and single-cell studies to understand vaccine performance in low-income countries.
Professor Nick Casewell
Professor Casewell leads research on snake venom variation and the development of new therapeutics, including monoclonal antibodies and small molecule inhibitors, to improve snakebite treatment efficacy. He is also the Director of the Centre for Snakebite Research and Interventions.
Dr Ben Morton
Dr Ben Morton is a Reader in Critical Care Medicine at Liverpool School of Tropical Medicine (LSTM) and Liverpool University Hospitals NHS Foundation Trust. Since completing his doctorate in 2016, he has developed a research focus on translational approaches to preventing and treating severe infection.
Working in partnership
Infection Innovation Consortium, iiCON
iiCON is a pioneering national partnership, led by LSTM, which brings together academia, industry, and the NHS to remove barriers to infection innovation, across eleven specialist platforms – from antimicrobial discovery and diagnostics validation to pharmacology and human challenge. Read more
The Pandemic Institute
LSTM is a founding partner in The Pandemic Institute – a partnership of academic, civic and health organisations with strong industry connections, dedicated to ensuring the world is better prepared for future pandemics. Building on a long history of research in infectious diseases and drug discovery, alongside a unique regional infrastructure of specialist facilities it provides a comprehensive response to emerging infections and pandemic threats.
Featured projects
TOCSINS drug trials
TOCSINS (Trial of Oral Combination Therapies for Snakebite Envenoming) is a groundbreaking clinical trial led by the Centre for Snakebite Research and Interventions (CSRI) at LSTM.
BRITE
Brings together universities and industry partners across the Liverpool City Region to build the biomanufacturing infrastructure needed to commercialise world-class biologics research.
FAME
Pre-clinical studies and computer modelling suggest that fusidic acid, an existing antibiotic, could be repurposed to treat onchocerciasis with a short, seven-day course of tablets.
Related news
Inaugural Lecture – Professor Christine Goffinet
52:42
125th Anniversary Scientific Symposium: Reimagining Solutions for the 22nd Century
In November 2024, Liverpool School of Tropical Medicine brought together global health experts from across the world for our flagship scientific symposium.
Hear from leading experts in Malaria and Neglected Tropical Disease